1
|
Eicher AK, Kechele DO, Sundaram N, Berns HM, Poling HM, Haines LE, Sanchez JG, Kishimoto K, Krishnamurthy M, Han L, Zorn AM, Helmrath MA, Wells JM. Functional human gastrointestinal organoids can be engineered from three primary germ layers derived separately from pluripotent stem cells. Cell Stem Cell 2022; 29:36-51.e6. [PMID: 34856121 PMCID: PMC8741755 DOI: 10.1016/j.stem.2021.10.010] [Citation(s) in RCA: 60] [Impact Index Per Article: 30.0] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 03/24/2021] [Revised: 07/22/2021] [Accepted: 10/20/2021] [Indexed: 02/08/2023]
Abstract
Human organoid model systems lack important cell types that, in the embryo, are incorporated into organ tissues during development. We developed an organoid assembly approach starting with cells from the three primary germ layers-enteric neuroglial, mesenchymal, and epithelial precursors-that were derived separately from human pluripotent stem cells (PSCs). From these three cell types, we generated human antral and fundic gastric tissue containing differentiated glands surrounded by layers of smooth muscle containing functional enteric neurons that controlled contractions of the engineered antral tissue. Using this experimental system, we show that human enteric neural crest cells (ENCCs) promote mesenchyme development and glandular morphogenesis of antral stomach organoids. Moreover, ENCCs can act directly on the foregut to promote a posterior fate, resulting in organoids with a Brunner's gland phenotype. Thus, germ layer components that are derived separately from PSCs can be used for tissue engineering to generate complex human organoids.
Collapse
Affiliation(s)
- Alexandra K. Eicher
- College of Medicine, University of Cincinnati, Cincinnati, OH, 45267, USA,Center for Stem Cell and Organoid Medicine (CuSTOM),Division of Developmental Biology, Cincinnati Children’s Hospital Medical Center (CCHMC), Cincinnati, OH, 45229, USA
| | - Daniel O. Kechele
- Center for Stem Cell and Organoid Medicine (CuSTOM),Division of Developmental Biology, Cincinnati Children’s Hospital Medical Center (CCHMC), Cincinnati, OH, 45229, USA
| | - Nambirajan Sundaram
- Center for Stem Cell and Organoid Medicine (CuSTOM),Division of Pediatric General and Thoracic Surgery, Cincinnati Children’s Hospital Medical Center (CCHMC), Cincinnati, OH, 45229, USA
| | - H. Matthew Berns
- Center for Stem Cell and Organoid Medicine (CuSTOM),Division of Developmental Biology, Cincinnati Children’s Hospital Medical Center (CCHMC), Cincinnati, OH, 45229, USA
| | - Holly M. Poling
- Center for Stem Cell and Organoid Medicine (CuSTOM),Division of Pediatric General and Thoracic Surgery, Cincinnati Children’s Hospital Medical Center (CCHMC), Cincinnati, OH, 45229, USA
| | - Lauren E. Haines
- Center for Stem Cell and Organoid Medicine (CuSTOM),Division of Developmental Biology, Cincinnati Children’s Hospital Medical Center (CCHMC), Cincinnati, OH, 45229, USA
| | - J. Guillermo Sanchez
- College of Medicine, University of Cincinnati, Cincinnati, OH, 45267, USA,Center for Stem Cell and Organoid Medicine (CuSTOM),Division of Developmental Biology, Cincinnati Children’s Hospital Medical Center (CCHMC), Cincinnati, OH, 45229, USA
| | - Keishi Kishimoto
- Division of Developmental Biology, Cincinnati Children’s Hospital Medical Center (CCHMC), Cincinnati, OH, 45229, USA,CuSTOM-RIKEN BDR Collaborative Laboratory, CCHMC, Cincinnati, OH, 45229, USA,Laboratory for Lung Development, RIKEN Center for Biosystems Dynamics Research (BDR), Kobe, 650-0047, Japan
| | - Mansa Krishnamurthy
- Center for Stem Cell and Organoid Medicine (CuSTOM),Division of Endocrinology, Cincinnati Children’s Hospital Medical Center (CCHMC), Cincinnati, OH, 45229, USA
| | - Lu Han
- Center for Stem Cell and Organoid Medicine (CuSTOM),Division of Developmental Biology, Cincinnati Children’s Hospital Medical Center (CCHMC), Cincinnati, OH, 45229, USA
| | - Aaron M. Zorn
- Center for Stem Cell and Organoid Medicine (CuSTOM),Division of Developmental Biology, Cincinnati Children’s Hospital Medical Center (CCHMC), Cincinnati, OH, 45229, USA
| | - Michael A. Helmrath
- Center for Stem Cell and Organoid Medicine (CuSTOM),Division of Pediatric General and Thoracic Surgery, Cincinnati Children’s Hospital Medical Center (CCHMC), Cincinnati, OH, 45229, USA
| | - James M. Wells
- Center for Stem Cell and Organoid Medicine (CuSTOM),Division of Developmental Biology, Cincinnati Children’s Hospital Medical Center (CCHMC), Cincinnati, OH, 45229, USA,Division of Endocrinology, Cincinnati Children’s Hospital Medical Center (CCHMC), Cincinnati, OH, 45229, USA,Lead Contact and Corresponding Author,Corresponding Author’s:
| |
Collapse
|
2
|
Fernández-Reina A, Urdiales JL, Sánchez-Jiménez F. What We Know and What We Need to Know about Aromatic and Cationic Biogenic Amines in the Gastrointestinal Tract. Foods 2018; 7:E145. [PMID: 30181486 PMCID: PMC6164962 DOI: 10.3390/foods7090145] [Citation(s) in RCA: 26] [Impact Index Per Article: 4.3] [Reference Citation Analysis] [Abstract] [Key Words] [Grants] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 08/01/2018] [Revised: 08/22/2018] [Accepted: 08/29/2018] [Indexed: 12/15/2022] Open
Abstract
Biogenic amines derived from basic and aromatic amino acids (B/A-BAs), polyamines, histamine, serotonin, and catecholamines are a group of molecules playing essential roles in many relevant physiological processes, including cell proliferation, immune response, nutrition and reproduction. All these physiological effects involve a variety of tissue-specific cellular receptors and signalling pathways, which conforms to a very complex network that is not yet well-characterized. Strong evidence has proved the importance of this group of molecules in the gastrointestinal context, also playing roles in several pathologies. This work is based on the hypothesis that integration of biomedical information helps to reach new translational actions. Thus, the major aim of this work is to combine scientific knowledge on biomolecules, metabolism and physiology of the main B/A-BAs involved in the pathophysiology of the gastrointestinal tract, in order to point out important gaps in information and other facts deserving further research efforts in order to connect molecular information with pathophysiological observations.
Collapse
Affiliation(s)
- Alberto Fernández-Reina
- Departamento de Biología Molecular y Bioquímica, Facultad de Ciencias, Universidad de Málaga, 29071 Málaga, Spain.
| | - José Luis Urdiales
- Departamento de Biología Molecular y Bioquímica, Facultad de Ciencias, Universidad de Málaga, 29071 Málaga, Spain.
- CIBER de Enfermedades Raras & IBIMA, Instituto de Salud Carlos III, 29010 Málaga, Spain.
| | - Francisca Sánchez-Jiménez
- Departamento de Biología Molecular y Bioquímica, Facultad de Ciencias, Universidad de Málaga, 29071 Málaga, Spain.
- CIBER de Enfermedades Raras & IBIMA, Instituto de Salud Carlos III, 29010 Málaga, Spain.
| |
Collapse
|
6
|
Rydning A, Bakkelund K, Chen D, Falkmer S, Grønbech JE. Role of bradykinin in gastric vasodilation caused by hypertonic saline and acid back diffusion. ACTA ACUST UNITED AC 2004; 119:139-48. [PMID: 15093708 DOI: 10.1016/j.regpep.2004.01.008] [Citation(s) in RCA: 3] [Impact Index Per Article: 0.2] [Reference Citation Analysis] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 05/09/2003] [Revised: 01/24/2004] [Accepted: 01/29/2004] [Indexed: 11/16/2022]
Abstract
Protective vasodilation in response to tissue injury and acid back diffusion is associated with release of bradykinin in the rat stomach. We hypothesized that bradykinin might be involved in mechanisms behind such vasodilation via influence on mast cells and sensory neurons. Acid back diffusion after mucosal barrier disruption with hypertonic saline evoked degranulation of mast cells in the rat stomach wall. Acid back diffusion was also associated with increased luminal release of histamine and gastric blood flow in normal rats, but not in mast cell-deficient rats. Bradykinin (BK(2)) receptor blockade inhibited degranulation of submucosal mast cells in the stomach and attenuated gastric vasodilation both in response to acid back diffusion and after stimulation of sensory neurons with capsaicin. Gastric vasodilation caused by mucosal injury with hypertonic saline alone was associated with degranulation of mucosal mast cells. These events were unaffected by inhibition of prostaglandin synthesis, whereas bradykinin (BK(2)) receptor blockade was associated with abolished vasodilation and inhibition of mucosal mast cell degranulation. We conclude that bradykinin is involved in gastric vasodilation caused by hypertonic injury alone via influence on mast cells, and by acid back diffusion via influence on both sensory neurons and mast cells.
Collapse
Affiliation(s)
- Astrid Rydning
- Department of Surgery, Norwegian University of Science and Technology, University Hospital Trondheim, St. Olavs Hospital, N-7006 Trondheim, Norway.
| | | | | | | | | |
Collapse
|